BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Cancer Epigenetics Society - ECPv5.3.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cancer Epigenetics Society
X-ORIGINAL-URL:https://ces.b2sg.org
X-WR-CALDESC:Events for Cancer Epigenetics Society
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20170326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20171029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20171022
DTEND;VALUE=DATE:20171124
DTSTAMP:20260729T105000
CREATED:20171022T093359Z
LAST-MODIFIED:20171022T093543Z
UID:19279-1508630400-1511481599@ces.b2sg.org
SUMMARY:Research Post Doctoral Fellow
DESCRIPTION:The laboratory headed by Ajay Goel\, PhD focuses on understanding the interplay between genetic and epigenetic alterations in colorectal\, pancreatic\, gastric and esophageal cancers. We are a multidisciplinary research group\, undertaking a number of collaborative projects involving large international consortia.  The projects will involve any/all of the following research focuses. \n\nExploration of the role of aberrant DNA methylation\, histone modifications and non-coding RNA’s (miRNA\, lncRNAs\, snoRNAs\, piRNAs etc.) in gastrointestinal cancers.\nEstablishment of innovative methodologies for the development of epigenetic and non-coding RNA’s-based biomarkers for the earlier diagnosis\, prognosis and predictive responses to chemotherapy in gastrointestinal neoplasia.\nA better understanding of the translational and clinical role of genetic and epigenetic signatures in gastrointestinal cancers.\nUnderstanding the genetic basis of early-onset and familial colorectal cancers.\nChemoprevention of gastrointestinal cancers using dietary nutraceuticals\, non-steroidal anti-inflammatory drugs (NSAIDs)\, and other drugs.\nMolecular mechanisms of cancer chemotherapy\, stem cells\, chemo-resistance and chemo-sensitization.\nGut microbiome\, and its influence on gastrointestinal cancers.\n\n  \nThe position is largely computational but involves substantial collaboration with wet-lab researchers providing data and is focused on fundamental biology.  This interdisciplinary position offers opportunities to address important questions in computational biology and cancer genomics with first access to large novel data sets from various genomic/epigenomic platforms.  We have a strong preference for bioinformaticians/computational biologists with a deep appreciation of biological phenomena or\, alternatively\, experimentalists with a solid background in bioinformatics/computational biology analysis of transcriptomic and genomic data with regard to detection of differentially expressed genes\, noncoding RNA’s\, DNA methylation and differential processing profiles.   \n  \nThis individual will also have the opportunity to develop original statistical and machine learning methodologies and analytical and computational tools to extract knowledge from complex and big data.  \nThe ideal candidate will possess: \n\nAn excellent track record of analyzing next generation sequencing data in cancer\, particularly whole genome\, RNASeq and methylation sequencing analysis including:\nDifferential expression analysis\, SNV calling\, indel calling\, rearrangement/translocation calling\, CNV identification and analysis.\n\n\nA good knowledge and understanding of cancer biology\nPassion for science and reproducible scientific work\nProficient in spoken and written English\nBeing comfortable in interacting with colleagues in an interdisciplinary setting
URL:https://ces.b2sg.org/event/bsw-postdoc-oct17/
LOCATION:Baylor Scott & White Health (BSWH)\,  3500 Gaston Ave\, Dallas\, TX\, 75246-2017\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/png:https://ces.b2sg.org/wp-content/uploads/2017/08/baylor-scott-white-bswh.png
END:VEVENT
END:VCALENDAR